medAmigo : drug compliance, drug adherence, patient compliance, patient adherence

Expected benefits for stakeholders

"All for one and one for all"

Key stakeholders - patient, physician, nurse, pharmacist, pharmaceutical industry - need to be motivated to participate in the program. This puts communication at the centre of the project to ensure that the importance of such a program is well understood.

The next stage is an acceptance phase. This may involve country-specific adaptations of the basic program, and it will vary from stakeholder to stakeholder. To achieve this, medAmigo solutions are customized as much as possible to the stakeholders’ needs, in terms of local (e.g. centre ethical committee requirement), regional (e.g. different language), country (e.g. legislation) specifics, cultural adaptations and technical aspects.

To successfully implement a medAmigo service very little work is required on the part of each stakeholder. In contrast, a successful medAmigo service’ implementation will bring important advantages to each participant.

 

WHO

BENEFITS

Patient

  • Enhance adherence
  • Decrease side-effects and prevent resistance
  • Maximize drug efficacy
  • Guarantee a better quality of life

Nurse

  • Optimize the time spent with your patient
  • Create a better relationship with your patient
  • Get a realistic measurement of your patient’s adherence

Pharmacist

  • Rapid and realistic results of the quality of execution of your patients
  • A simple IT alternative to pill-count and questionnaires

Physician

  • Optimize the time spent with your patient
  • Create a better relationship with your patient
  • Get a realistic measurement of your patient’s adherence

Pharmaceutical industry

  • More patients under treatment (recruit more)
  • Patients execute better (better adherence)
  • Patients stay longer under treatment (better persistence)
  • Provide a reliable service that creates brand loyalty